Modulatory effect of mycophenolate mofetil on carrageenan-induced inflammation in the mouse air pouch model

International Immunopharmacology

Volumn 13, Issue 4, 2012, Pages 476-482

  Dalmarco, Eduardo Monguilhott ^a   Astolfi, Giliard ^a   De Liz, Rafael ^a   De Córdova, Caio Maurício Mendes ^b   Fröde, Tânia Silvia ^a  

^a Department of Clinical Analyses   (Brazil)

^b Centre of Health Sciences   (Brazil)

Author keywords

Cytokines; Exudate; Leukocytes; Mycophenolate mofetil; Nitric oxide

Indexed keywords

ADENOSINE DEAMINASE; CARRAGEENAN; DEXAMETHASONE; IBUPROFEN; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYELOPEROXIDASE; NITRATE; NITRITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ENZYME ACTIVITY; INFLAMMATION; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; CARRAGEENAN; CELL MOVEMENT; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOSUPPRESSION; INFLAMMATION MEDIATORS; LEUKOCYTES; MICE; MYCOPHENOLIC ACID; NITRIC OXIDE; PEROXIDASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84862201714     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.04.012     Document Type: Article

References (26)

1. G.W. Schmid-Schonbein Analysis of Inflammation Annu Rev Biomed Eng 8 2006 93 151
2. K. Nakagome, and M. Nagata Pathogenesis of airway inflammation in bronchial asthma Auris Nasus Larynx 38 2011 555 563
3. D.L. Scott, F. Wolfe, and T.W. Huizinga Rheumatoid arthritis Lancet 376 2010 1094 1108
4. H.F. McFarland, and R. Martin Multiple sclerosis: a complicated picture of autoimmunity Nat Immunol 8 2007 913 919
5. A.K. Orvis, S.K. Wesson, T.S. Breza Jr., A.A. Church, C.L. Mitchell, and S.W. Watkins Mycophenolate mofetil in dermatology J Am Acad Dermatol 60 2009 183 199
6. M.C. Villarroel, M. Hidalgo, and A. Jimeno Mycophenolate mofetil: An update Drugs Today (Barc) 45 2009 521 532
7. A.C. Allison, and E.M. Eugui Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection Transplantation 80 2 Suppl. 2005 S181 S190
8. G.M. Sahin, S. Sahin, G. Kantarci, and H. Ergin Mycophenolate mofetil treatment for therapy-resistant glomerulopathies Nephrology (Carlton) 12 2007 285 288
9. A. Sinclair, G. Appel, M.A. Dooley, E. Ginzler, D. Isenberg, and D. Jayne Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS) Lupus 16 2007 972 980
10. C. Heatwole, and E. Ciafaloni Mycophenolate mofetil for myasthenia gravis: a clear and present controversy Neuropsychiatr Dis Treat 4 2008 1203 1209
11. R. Aggarwal, and C.V. Oddis Therapeutic approaches in myositis Curr Rheumatol Rep 13 2011 182 191
12. E.M. Dalmarco, C.M.M. Córdova, and T.S. Fröde Evidence of an anti-inflammatory effect of mycophenolate mofetil in a murine model of pleurisy Exp Lung Res 37 2011 399 407
13. A.D. Sedgwick, and P.A. Lees Comparison of air pouch, sponge and pleurisy models of acute carrageenan inflammation in the rat Agents Actions 18 1986 439 446
14. M. Romano, R. Faggioni, M. Sironi, S. Sacco, B. Echtenacher, and E. Di Santo Carrageenan-induced acute inflammation in the mouse air pouch synovial model. Role of tumour necrosis factor Mediators Inflamm 6 1997 32 38
15. J. Benincá, A.B. Montanher, S.M. Zucolotto, E.P. Schenkel, and T.S. Fröde Evaluation of the anti-inflammatory efficacy of Passiflora edulis Food Chem 104 2007 1097 1105
16. S.V.G. Vigil, R. De Liz, Y.S. Medeiros, and T.S. Fröde Efficacy of tacrolimus in inhibiting inflammation caused by carrageenan in a murine model of air pouch Transpl Immunol 19 2008 25 29
17. T.S. Rao, J.L. Currie, A.L. Shaffer, and P.C. Isakson Comparative evaluation of arachidonic acid (aa)- and tetradecanoylphorbol acetate (tpa)-induced dermal inflammation Inflammation 17 1993 723 741
18. G. Giusti, and B. Galanti Adenosine deaminase: colorimetric method Bergmeyer Hu, Methods of enzymatic analysis 1984 Verlac Chemie Press Weinheim, Germany 315 323
19. 15N] nitrate in biological fluids Anal Biochem 126 1982 131 138
20. T.S. Fröde, and Y.S. Medeiros Myeloperoxidase and adenosine-deaminase levels in the pleural fluid leakage induced by carrageenan in the mouse model of pleurisy Mediators Inflamm 10 2001 223 227
21. D. Lau, and S. Baldus Myeloperoxidase and its contributory role in inflammatory vascular disease Pharmacol Ther 111 2006 16 126
22. A.S. Farivar, B. MacKinnon-Patterson, A.D. Barnes, and M.S. Mulligan The effect of anti-inflammatory properties of mycophenolate mofetil on the development of lung reperfusion injury J Heart Lung Transplant 24 2005 2235 2242
23. S. Cuzzocrea, E. Mazzon, L. Dugo, A. Barbera, T. Centorrino, and A. Ciccolo Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan Shock 6 2001 51 58
24. K.S. Lee, S.R. Kim, S.J. Park, K.H. Min, K.Y. Lee, and Y.H. Choe Mast cells can mediate vascular permeability through regulation of the PI3K-HIF-1alpha-VEGF axis Am J Respir Crit Care Med 178 2008 787 797
25. C.A. Jonsson, and H. Carlsten Mycophenolic acid inhibits inosine 5′-monophosphate dehydrogenase and suppresses production of pro-inflammatory cytokines, nitric oxide, and LDH in macrophages Cell Immunol 216 2002 93 101
26. Y. Wu, J. Dong, L. Yuan, C. Liang, K. Ren, and W. Zhang Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy Cytokine 44 2008 85 91